Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella Typhimurium surface antigens are major molecular components present on the surface of Salmonella enterica subsp. enterica serovar Typhimurium, a Gram-negative bacterium and important human pathogen[1][3][4][5][7][8][9][10]. These surface antigens include the lipopolysaccharide (LPS) O-antigen (a diverse polysaccharide chain), H-antigens (flagellar proteins), and various outer membrane proteins[3][4][5][8][10]. The O-antigen is a highly variable polysaccharide that determines the serotype, acts as a barrier to immune defenses, and serves as a critical target for vaccine development due to its strong immunogenicity[1][3][5][7][9][10]. H-antigens (flagellar proteins) and outer membrane proteins are also antigenic, supporting serotyping and immune recognition. These antigens play essential roles in virulence, immune evasion, colonization, and modulation of host immune responses. Their marked antigenic diversity presents challenges for vaccine and diagnostic design, making them a major focus in the fight against invasive Salmonella infections[5][9][10].
Induction of bactericidal antibodies (e.g. via vaccine or natural infection) Opsonization and complement-mediated killing Immune system priming for antibody-mediated recognition Diagnostic detection (antibody tests)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella Typhimurium surface antigen.